April 25, 2025
A recent study featured in the Journal of Cosmetic Dermatology has analyzed the impact of a topical product containing OS-01. This is a senotherapeutic peptide that targets senescence, affecting the skin's barrier function and multiple aging biomarkers [1]. Conducted by a team from OneSkin alongside academic partners, this initial trial aimed to determine if skin...
November 09, 2020
If there is one thing about aging research that is almost sure to grab public attention, it is something that has a visible effect. A new product on the market that claims to reduce senescent cells in aged skin could achieve that, assuming that the pending human study is successful. OneSkin recently released OS-01, a...
